Lifestyle Factors and Breast Cancer in Females with PTEN Hamartoma Tumor Syndrome (PHTS).

alcohol drinking body mass index breast neoplasm exercise hamartoma syndrome multiple

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
27 Feb 2024
Historique:
received: 08 01 2024
revised: 15 02 2024
accepted: 17 02 2024
medline: 13 3 2024
pubmed: 13 3 2024
entrez: 13 3 2024
Statut: epublish

Résumé

Females with PTEN Hamartoma Tumor Syndrome (PHTS) have breast cancer risks up to 76%. This study assessed associations between breast cancer and lifestyle in European female adult PHTS patients. Data were collected via patient questionnaires (July 2020-March 2023) and genetic diagnoses from medical files. Associations between lifestyle and breast cancer were calculated using logistic regression corrected for age. Index patients with breast cancer before PHTS diagnosis (breast cancer index) were excluded for ascertainment bias correction. In total, 125 patients were included who completed the questionnaire at a mean age of 44 years (SD = 13). This included 21 breast cancer indexes (17%) and 39 females who developed breast cancer at 43 years (SD = 9). Breast cancer patients performed about 1.1 times less often 0-1 times/week physical activity than ≥2 times (OR

Identifiants

pubmed: 38473316
pii: cancers16050953
doi: 10.3390/cancers16050953
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : PTEN Research Foundation
ID : 17-002
Organisme : Region Stockholm
ID : FoUI-973659

Auteurs

Linda A J Hendricks (LAJ)

Department of Human Genetics, Radboudumc Expert Center for PHTS, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.
Radboud Institute for Medical Innovation, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.

Katja C J Verbeek (KCJ)

Department of Human Genetics, Radboudumc Expert Center for PHTS, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.
Radboud Institute for Medical Innovation, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.

Janneke H M Schuurs-Hoeijmakers (JHM)

Department of Human Genetics, Radboudumc Expert Center for PHTS, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.

Arjen R Mensenkamp (AR)

Department of Human Genetics, Radboudumc Expert Center for PHTS, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.
Radboud Institute for Medical Innovation, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.

Hilde Brems (H)

Department of Human Genetics, University of Leuven, 3000 Leuven, Belgium.

Robin de Putter (R)

Center for Medical Genetics, Ghent University Hospital, 9000 Ghent, Belgium.

Violetta C Anastasiadou (VC)

Karaiskakio Foundation, Nicosia Cyprus and Archbishop Makarios III Children's Hospital, Nicosia 2012, Cyprus.

Marie-Charlotte Villy (MC)

Service de Génétique, Institut Curie, 75248 Paris, France.

Arne Jahn (A)

Institute for Clinical Genetics, Faculty of Medicine Carl Gustav Carus, Technische Universitat Dresden, 01062 Dresden, Germany.
Hereditary Cancer Syndrome Center Dresden, 01307 Dresden, Germany.
German Cancer Consortium (DKTK), 69120 Dresden, Germany.

Verena Steinke-Lange (V)

Medical Genetics Center, 80335 Munich, Germany.
Arbeitsgruppe Erbliche Gastrointestinale Tumore, Medizinische Klinik und Poliklinik IV-Campus Innenstadt, Klinikum der Universität München, 81377 Munich, Germany.

Margherita Baldassarri (M)

Medical Genetics, University of Siena, 53100 Siena, Italy.
Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.
Genetica Medica, Azienda Ospedaliero-Universitaria Senese, 53100 Siena, Italy.

Arvids Irmejs (A)

Institute of Oncology, Riga Stradins University, 1007 Riga, Latvia.
Breast Unit, Pauls Stradins Clinical University Hospital, 1002 Riga, Latvia.

Mirjam M de Jong (MM)

Department of Genetics, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands.

Thera P Links (TP)

Department of Endocrinology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands.

Edward M Leter (EM)

Department of Clinical Genetics, Maastricht University Medical Center, 6229 ER Maastricht, The Netherlands.

Daniëlle G M Bosch (DGM)

Department of Clinical Genetics, Erasmus MC Rotterdam, 3015 GD Rotterdam, The Netherlands.

Hildegunn Høberg-Vetti (H)

Western Norway Familial Cancer Center, Department of Medical Genetics, Haukeland University Hospital, 5021 Bergen, Norway.

Marianne Tveit Haavind (M)

Western Norway Familial Cancer Center, Department of Medical Genetics, Haukeland University Hospital, 5021 Bergen, Norway.

Kjersti Jørgensen (K)

Department of Medical Genetics, Oslo University Hospital, 0450 Oslo, Norway.

Lovise Mæhle (L)

Department of Medical Genetics, Oslo University Hospital, 0450 Oslo, Norway.

Ana Blatnik (A)

Department of Clinical Cancer Genetics, Institute of Oncology Ljubljana, 1000 Ljubljana, Slovenia.

Joan Brunet (J)

Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL-IDIBGI, 08916 Barcelona, Spain.

Esther Darder (E)

Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL-IDIBGI, 08916 Barcelona, Spain.

Emma Tham (E)

Department of Clinical Genetics, Karolinska University Hospital, 14186 Stockholm, Sweden.
Department of Molecular Medicine and Surgery, Karolinska Institute, 17177 Stockholm, Sweden.

Nicoline Hoogerbrugge (N)

Department of Human Genetics, Radboudumc Expert Center for PHTS, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.
Radboud Institute for Medical Innovation, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.

Janet R Vos (JR)

Department of Human Genetics, Radboudumc Expert Center for PHTS, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.
Radboud Institute for Medical Innovation, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.

Classifications MeSH